These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 21945270)
21. Development of biodegradable nanoparticles for liver-specific ribavirin delivery. Ishihara T; Kaneko K; Ishihara T; Mizushima T J Pharm Sci; 2014 Dec; 103(12):4005-4011. PubMed ID: 25335768 [TBL] [Abstract][Full Text] [Related]
22. New high throughput screening method for drug release measurements. Pelczarska A; Delie F; Domańska U; Carrupt PA; Martel S Eur J Pharm Biopharm; 2013 Sep; 85(1):151-7. PubMed ID: 23958326 [TBL] [Abstract][Full Text] [Related]
23. Functionalized PLA polymers to control loading and/or release properties of drug-loaded nanoparticles. Thauvin C; Schwarz B; Delie F; Allémann E Int J Pharm; 2018 Sep; 548(2):771-777. PubMed ID: 29104059 [TBL] [Abstract][Full Text] [Related]
24. PLA/PLGA nanoparticles for sustained release of docetaxel. Musumeci T; Ventura CA; Giannone I; Ruozi B; Montenegro L; Pignatello R; Puglisi G Int J Pharm; 2006 Nov; 325(1-2):172-9. PubMed ID: 16887303 [TBL] [Abstract][Full Text] [Related]
25. Drug delivery across intact and disrupted skin barrier: Identification of cell populations interacting with penetrated thermoresponsive nanogels. Rancan F; Giulbudagian M; Jurisch J; Blume-Peytavi U; Calderón M; Vogt A Eur J Pharm Biopharm; 2017 Jul; 116():4-11. PubMed ID: 27865989 [TBL] [Abstract][Full Text] [Related]
26. pH-responsive biocompatible fluorescent polymer nanoparticles based on phenylboronic acid for intracellular imaging and drug delivery. Li S; Hu K; Cao W; Sun Y; Sheng W; Li F; Wu Y; Liang XJ Nanoscale; 2014 Nov; 6(22):13701-9. PubMed ID: 25278283 [TBL] [Abstract][Full Text] [Related]
27. Microcosmic mechanisms for protein incomplete release and stability of various amphiphilic mPEG-PLA microspheres. Wei Y; Wang YX; Wang W; Ho SV; Qi F; Ma GH; Su ZG Langmuir; 2012 Oct; 28(39):13984-92. PubMed ID: 22937802 [TBL] [Abstract][Full Text] [Related]
28. PLA-microparticles formulated by means a thermoreversible gel able to modify protein encapsulation and release without being co-encapsulated. Leo E; Ruozi B; Tosi G; Vandelli MA Int J Pharm; 2006 Oct; 323(1-2):131-8. PubMed ID: 16815657 [TBL] [Abstract][Full Text] [Related]
29. Recent advances in the preparation progress of protein/peptide drug loaded PLA/PLGA microspheres. Xu FH; Zhang Q Yao Xue Xue Bao; 2007 Jan; 42(1):1-7. PubMed ID: 17520799 [TBL] [Abstract][Full Text] [Related]
30. Amphiphilic chitosan-grafted-functionalized polylactic acid based nanoparticles as a delivery system for doxorubicin and temozolomide co-therapy. Di Martino A; Sedlarik V Int J Pharm; 2014 Oct; 474(1-2):134-45. PubMed ID: 25124059 [TBL] [Abstract][Full Text] [Related]
32. Poly[acrylonitrile-co-(N-vinyl pyrrolidone)] nanoparticles - Composition-dependent skin penetration enhancement of a dye probe and biocompatibility. Zhang N; Said A; Wischke C; Kral V; Brodwolf R; Volz P; Boreham A; Gerecke C; Li W; Neffe AT; Kleuser B; Alexiev U; Lendlein A; Schäfer-Korting M Eur J Pharm Biopharm; 2017 Jul; 116():66-75. PubMed ID: 27989766 [TBL] [Abstract][Full Text] [Related]
33. Pluronic P85/poly(lactic acid) vesicles as novel carrier for oral insulin delivery. Xiong XY; Li QH; Li YP; Guo L; Li ZL; Gong YC Colloids Surf B Biointerfaces; 2013 Nov; 111():282-8. PubMed ID: 23838194 [TBL] [Abstract][Full Text] [Related]
34. [Preparation and in vitro evaluation of brucine-loaded polylacticacid nanoparticles]. Zhao J; Liu Z; Xu J; Yu Y; Feng N Zhongguo Zhong Yao Za Zhi; 2009 Sep; 34(18):2322-4. PubMed ID: 20030079 [TBL] [Abstract][Full Text] [Related]
35. Improved antifungal activity of itraconazole-loaded PEG/PLA nanoparticles. Essa S; Louhichi F; Raymond M; Hildgen P J Microencapsul; 2013; 30(3):205-17. PubMed ID: 22894166 [TBL] [Abstract][Full Text] [Related]
36. Low molecular weight polylactic acid as a matrix for the delayed release of pesticides. Zhao J; Wilkins RM J Agric Food Chem; 2005 May; 53(10):4076-82. PubMed ID: 15884842 [TBL] [Abstract][Full Text] [Related]
37. Effect of enzymatic degradation on the release kinetics of model drug from Pluronic F127/poly(lactic acid) nano-particles. Xiong XY; Tam KC; Gan LH J Control Release; 2005 Nov; 108(2-3):263-70. PubMed ID: 16199106 [TBL] [Abstract][Full Text] [Related]
38. Innovative drug vehicle for local treatment of inflammatory skin diseases: Ex vivo and in vivo screening of five topical formulations containing poly(lactic acid) (PLA) nanoparticles. Boisgard AS; Lamrayah M; Dzikowski M; Salmon D; Kirilov P; Primard C; Pirot F; Fromy B; Verrier B Eur J Pharm Biopharm; 2017 Jul; 116():51-60. PubMed ID: 27702687 [TBL] [Abstract][Full Text] [Related]
39. Low molecular weight poly(lactic acid) microparticles for controlled release of the herbicide metazachlor: preparation, morphology, and release kinetics. Stloukal P; Kucharczyk P; Sedlarik V; Bazant P; Koutny M J Agric Food Chem; 2012 Apr; 60(16):4111-9. PubMed ID: 22480233 [TBL] [Abstract][Full Text] [Related]
40. Poly(lactic acid) nanoparticles coated with combined WGA and water-soluble chitosan for mucosal delivery of β-galactosidase. Sheng Y; He H; Zou H Drug Deliv; 2014 Aug; 21(5):370-8. PubMed ID: 24797098 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]